Spirig HealthCare AG - Co-Olmesartan Amlo Spirig HC 40 mg/5 mg/25 mg, Filmtabletten | | 67447 | | 03 | | Co-Olmesartan Amlo Spirig HC 40 mg/5 mg/25 mg | | Filmtabletten | | C09DX03 | | Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide | | 22.04.2020 | | |
| Composition | olmesartanum medoxomilum 40 mg, amlodipinum 5 mg ut amlodipini besilas, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, lactosum monohydricum 212.065 mg, Überzug: hypromellosum, lactosum monohydricum 3.92 mg, macrogolum 4000, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto. | Packungsbestandteile | | Comprimés filmés | | | Principe actif | Concentr. |
---|
Amlodipine | 5 mg | Hydrochlorothiazide | 25 mg | Olmesartanum Medoxomilum | 40 mg |
| BAG: Principe actif | Concentr. |
---|
Amlodipine | 5 mg | Hydrochlorothiazide | 25 mg | Olmesartan Medoxomil | 40 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Flavum) | | | (Rubrum) | | | Cellulosum Microcristallinum | | | Crospovidonum | | | E 171 | | color. | E 172 | | color. | Hypromellosum | | Überzug | Lactose Monohydrate | 3.92 mg | | Macrogol | 4000 | | Magnesii Stearas | | | Pro Compresso Obducto | | | Silica Colloidalis Anhydrica | | |
| |
| |
|